Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Bevacizumab × Clear all

Phase

Phase 2 20 Phase 1 9 Phase 1/2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 74 Ovarian Neoplasms 28 Carcinoma, Non-Small-Cell Lung 24 Breast Neoplasms 24 Colonic Neoplasms 20 Rectal Neoplasms 18 Neoplasms 16 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 11 Glioblastoma 10 Carcinoma, Renal Cell 7 Brain Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Lung Neoplasms 6 Uterine Cervical Neoplasms 5 Intestinal Neoplasms 5 Gastrointestinal Neoplasms 5 Digestive System Neoplasms 5 Brenner Tumor 5 Recurrence 4 Glioma 4 Rectal Diseases 3 Peritoneal Neoplasms 3 Liver Neoplasms 3 Intestinal Diseases 3 Gastrointestinal Diseases 3 Digestive System Diseases 3 Colonic Diseases 3 Carcinoma, Ovarian Epithelial 3

Interventions

Oxaliplatin 51 Capecitabine 42 Fluorouracil 30 Cisplatin 30 S 1 (combination) 21 Docetaxel 16 Paclitaxel 15 Leucovorin 14 pembrolizumab 10 apatinib 10 Irinotecan 10 titanium silicide 9 XELOX 9 Nivolumab 8 Epirubicin 8 Drug Therapy 8 Hyperthermic Intraperitoneal Chemotherapy 7 Tegafur 6 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Trastuzumab 5 Chemotherapy, Adjuvant 5 Surgical Procedures, Operative 4 S-1 plus cisplatin 4 Ramucirumab 4 Gastrectomy 4 zolbetuximab 3 tislelizumab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00887822 2017-03-01

AVATAR

Hoffmann-La Roche

Phase 3 Completed

202 enrolled 20 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡